Author: openjargon

The All Ordinaries Index (ASX: XAO) is down 0.4% in Tuesday morning trade, but that’s not holding back this ASX All Ords silver share.

The outperforming miner in question is Andean Silver Ltd (ASX: ASL).

Andean Silver shares closed yesterday trading for $1.83. At the time of writing, shares are swapping hands for $1.86 apiece, up 1.6%.

This outperformance follows a promising exploration update from the company’s Cerro Bayo Silver-Gold Project, located in Chile.

Here’s what we know.

ASX All Ords silver share lifts on bonanza-grade silver-gold results

The Andean Silver shares price is marching higher today after the miner reported that it has defined a “highly prospective” new area at Cerro Bayo.

The ASX All Ords silver share said the area has the potential to host a major silver-gold system, rather than isolated vein occurrences. And the new trend, named the Juanita Prospect, is situated just six kilometres from the Laguna Verde processing facility.

Noting that mineralised breccia zones were observed with widths up to 18 metres, some of the top initial outcrop mapping and rock chip sampling of these zones returned results that included:

• 62,663g/t silver equivalent (25,047g/t Ag & 453.2g/t Au) or 755g/t AuEq
• 41,489g/t silver equivalent (37,024g/t Ag & 53.8g/t Au) or 500g/t AuEq

Andean Silver said that prior historic scout drilling and channel sampling programs conducted in this area hadn’t comprehensively tested the high-grade breccia zones, with only five holes and channels intersecting parts of this higher-grade system.

The ASX All Ords silver share is now progressing with geological mapping and sawn channel sampling along the two-kilometre-long Juanita trend to further define the extent of the high-grade silver gold mineralisation prior to drill testing the zone.

What did Andean Silver management say?

Commenting on the results helping lift the ASX All Ords silver share today, Andean Silver managing director Matthew Allen said, “Juanita is emerging as a potentially significant silver-gold prospect.”

Allen added:

Its mineralisation differs from the vein-style deposits common across the company’s tenure, with high-grade silver and gold occurring over a substantial strike length and through multiple mineralising events.

Juanita historically has remained underexplored for 20 years due to the subtle surface expression of the system exposed on surface and limited intersection in historic scout drilling.

Juanita represents a third new large exploration area identified outside the existing resources at the Cerro Bayo Project, which include the Guanaco and Droughtmaster corridors, building Andean’s future prospect pipeline.

With the miner reporting $53.4 million in cash at the end of the March quarter, it said it is well-funded for the growth drilling and future feasibility works ahead.

The post Why is this ASX All Ords silver share jumping higher in Tuesday’s slumping market? appeared first on The Motley Fool Australia.

More reading

• Andean Silver Bonanza silver-gold unearthed at Cerro Bayo’s Juanita prospect

Motley Fool contributor Bernd Struben has no position in any of the stocks mentioned. The Motley Fool Australia’s parent company Motley Fool Holdings Inc. has no position in any of the stocks mentioned. The Motley Fool Australia has no position in any of the stocks mentioned. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

Hub24 Ltd (ASX: HUB) has reported net platform inflows of a record $18.9 billion for the past financial year, up 20%.

Growing demand for financial advice

The financial services platform provider said total funds under administration sat at $164.3 billion at the end of June, also up 20%, comprised of platform funds under administration of $139.5 billion and portfolio, administration and reporting services funds under administration of $24.8 billion.

The company added:

Hub24 delivered strong growth in Q4 FY26, with Platform funds under administration increasing 9% over the quarter to $139.5 billion as at 30 June 2026 (up 24% on previous corresponding period). This reflected continued momentum in net inflows of $4.2 billion, alongside positive market movements of $7.5 billion. In the context of market volatility and the recent tax changes proposed in the Federal Budget, the net inflows were stable on the previous corresponding period when excluding large migrations, with year-on-year growth in superannuation net inflows offset by lower net inflows into Investor Directed Portfolio Services.

Hub24 said during the past quarter, the total number of advisers using its platform increased by 100 to 5,649.

The company said in the most recent data collected by industry analyst Plan For Life, it ranked first in both quarterly and annual net inflows for a 10th consecutive quarter.

Hub24 added:

Hub24 also achieved the largest annual market share gain of all platform providers, increasing market share to 9.9% as at 31 March 2026 (up from 8.6% in the previous corresponding period), and is ranked the sixth largest platform by fund under administration.

The company said strong demand for financial advice was underpinned by demographic trends and Australia’s compulsory superannuation system.

The company added:

The proposed tax changes announced in the Federal Budget further reinforce the need for professional advice and the attractiveness of the superannuation system. With these structural growth drivers and a strong pipeline of opportunities across new and existing relationships, Hub24 is well positioned to deliver ongoing growth.

Broker says shares are looking cheap

Morgan Stanley has included Hub24 in its small-mid cap ideas list, saying in a note to clients that a broader sell-off in Australian technology growth stocks has pushed its share price lower.

Morgan Stanley says Hub24 has “delivered industry leading net flows and funds under administration growth as well as operating leverage in recent periods, yet has underperformed its closest peers”, which are Netwealth Ltd (ASX: NWL), Praemium Ltd (ASX: PPS), and AMP Ltd (ASX: AMP) on a year-to-date basis.

The broker said they believed the Federal Budget created more demand for financial advice and increased relative tax advantages for superannuation, which would benefit Hub24.

Morgan Stanley has a price target of $120 on Hub24 shares compared to $83.97 currently.

The post This ASX financial services company has just reported a 20% jump in funds under management appeared first on The Motley Fool Australia.

More reading

• HUB24 earnings: Record $18.9bn net inflows lift FUA
• 4 ASX share tips from 4 brokers, for returns better than 40%
• Where to invest $10,000 in ASX 200 shares in July
• The superannuation concessional contributions cap just rose to $32,500. Here’s how to make the most of it
• New parents are now earning superannuation on parental leave. Here’s how to make the most of it

Motley Fool contributor Cameron England has positions in Hub24. The Motley Fool Australia’s parent company Motley Fool Holdings Inc. has positions in and has recommended Hub24, Netwealth Group, and Praemium. The Motley Fool Australia has positions in and has recommended Netwealth Group. The Motley Fool Australia has recommended Hub24. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

Telix Pharmaceuticals Ltd (ASX: TLX) shares are charging higher today.

Shares in the S&P/ASX 200 Index (ASX: XJO) diagnostic and therapeutic product developer closed yesterday trading for $15.10. In early morning trade on Tuesday, shares are changing hands for $15.48 apiece, up 2.5%.

For some context, the ASX 200 is down 0.6% at this same time.

Telix shares have been on fire since plumbing a one-year closing low of $8.63 on 16 February. Indeed, with today’s intraday lift factored in, the ASX 200 healthcare share has surged 79.4% since that low.

Here’s what’s catching investor interest today.

Telix shares jump on revenue growth

Telix shares are outperforming following the release of the company’s second-quarter results (Q2 2026), covering the six months to 30 June.

Highlights included a 21% year-on-year revenue boost to US$247 million (AU$353 million). Second-quarter revenue was up 7% from the prior quarter.

The company’s Precision Medicine segment brought in US$202 million of that quarterly revenue, a 30% increase from Q2 2025 and up 9% from last quarter.

The quarter also saw Telix finalise its strategic collaboration with antibody discovery and development platform developer Regeneron. The two companies will now work to jointly develop and commercialise next-generation radiopharmaceutical therapies.

Looking at what could impact Telix shares in the months ahead, the company forecasts that full-year 2026 revenue and other income will exceed US$1 billion. Revenue was reported to be tracking in line with the upper end of Telix’s 2026 guidance of US$950 million to US$970 million, plus US$40 million non-refundable other income from Regeneron.

On the expenditure side, Telix increased its full-year 2026 R&D expenditure guidance to US$230 million to US$270 million. The company said the increased spend will support the advancement of high-value clinical programs beyond its original R&D forecast.

What did management say?

Commenting on the results helping boost Telix shares today, CEO Christian Behrenbruch said, “We delivered another quarter of growth with US dose volumes increasing 7% during the quarter, driven by growing demand for Gozellix and continued strength across our PSMA7 imaging portfolio.”

Behrenbruch added:

This performance underscores the strength of our differentiated two-product PSMA imaging strategy and reinforces Telix’s market leadership, built on clinical differentiation, supply chain resilience and commercial execution. During the quarter, we achieved key regulatory, commercial and clinical milestones across both our Precision Medicine and Therapeutics businesses.

Looking ahead, Behrenbruch concluded:

We are tracking in line with the upper end of our FY 2026 revenue guidance and are investing further in R&D to accelerate a number of high-value programs that have the potential to create significant future growth and shareholder value.

The post Up 79% since February, why are Telix shares jumping higher again on Tuesday? appeared first on The Motley Fool Australia.

More reading

• Top 3 ASX healthcare stocks to watch
• Telix Pharmaceuticals: Q2 2026 revenue jumps 21%
• These are the 10 most shorted ASX shares
• Down 9%: Is the rebound over for Telix shares?
• These are the 10 most shorted ASX shares

Motley Fool contributor Bernd Struben has no position in any of the stocks mentioned. The Motley Fool Australia’s parent company Motley Fool Holdings Inc. has positions in and has recommended Telix Pharmaceuticals. The Motley Fool Australia has recommended Telix Pharmaceuticals. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

The WAM Income Maximiser Ltd (ASX: WMX) share price is in focus after the company announced a fully franked monthly dividend of 0.66 cents per share, payable at the end of October 2026.

What did WAM Income Maximiser report?

• Dividend of 0.66 cents per share, fully franked
• Record date: 20 October 2026
• Ex-dividend date: 19 October 2026
• Payment date: 30 October 2026
• Dividend covers the October 2026 period
• Dividend Reinvestment Plan (DRP) available, no discount applied

What else do investors need to know?

WAM Income Maximiser continues its established pattern of delivering monthly, fully franked dividends with this latest announcement. The dividend is set at 0.66 cents per share, in line with recent payments, offering ongoing income to shareholders.

Investors can choose to reinvest their dividends via the company’s Dividend Reinvestment Plan (DRP). The DRP will operate at no discount, with the reinvestment price based on the volume weighted average market price across the four trading days from the ex-dividend date.

It’s important to note that shareholders need to confirm their DRP participation by 5pm on Thursday, 22 October 2026, if they wish to reinvest their dividends.

What’s next for WAM Income Maximiser?

WAM Income Maximiser remains focused on delivering regular, tax-effective income to shareholders through monthly, fully franked dividends. The ongoing DRP provides flexibility for investors seeking to accumulate more shares.

Looking ahead, the company will likely maintain its dividend strategy while monitoring market conditions and the performance of its investment portfolio.

WAM Income Maximiser share price snapshot

Over the past 12 months, WAM Income Maximiser shares have risen 4%, outperforming the S&P/ASX All Ords Index (ASX: XAO), which has risen 1% over the same period.

View Original Announcement

The post WAM Income Maximiser announces fully franked October 2026 dividend appeared first on The Motley Fool Australia.

More reading

• Andean Silver Bonanza silver-gold unearthed at Cerro Bayo’s Juanita prospect
• Ophir High Conviction Fund announces FY26 unfranked distribution
• 5 ASX All Ords shares that ripped 200% to 400% in FY26

Motley Fool contributor Laura Stewart has no position in any of the stocks mentioned. The Motley Fool Australia’s parent company Motley Fool Holdings Inc. has no position in any of the stocks mentioned. The Motley Fool Australia has no position in any of the stocks mentioned. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips. This article was prepared with the assistance of Large Language Model (LLM) tools for the initial summary of the company announcement. Any content assisted by AI is subject to our robust human-in-the-loop quality control framework, involving thorough review, substantial editing, and fact-checking by our experienced writers and editors holding appropriate credentials. The Motley Fool Australia stands behind the work of our editorial team and takes ultimate responsibility for the content published by The Motley Fool Australia.

The HUB24 Ltd (ASX: HUB) share price is in focus today after the company announced record net inflows of $18.9 billion in FY26, up 20% on the prior comparable period (pcp), and total Funds Under Administration (FUA) hitting $164.3 billion, up 20% on pcp.

What did HUB24 report?

• Platform net inflows reached a record $18.9 billion, up 20% on pcp (excluding large migrations)
• Total FUA stood at $164.3 billion as at 30 June 2026, up 20% on pcp
• Platform FUA increased to $139.5 billion, up 24% on pcp
• PARS FUA was $24.8 billion, up 5% on pcp
• Active advisers using the platform rose to 5,649, up 11% on pcp
• Class Super accounts increased by 5% to 226,767; NowInfinity document orders rose 15%

What else do investors need to know?

The HUB24 Platform was ranked first for both quarterly and annual net inflows for the tenth consecutive quarter and retained the highest Net Promoter Score (NPS) in prominent industry surveys. Market share increased to 9.9% as at 31 March 2026, making HUB24 the sixth largest platform by FUA in Australia.

HUB24 continued to invest in innovation, launching its lifetime super solution in partnership with TAL, which expanded the range of retirement options for advisers and clients. The company also enhanced its Class and NowInfinity offerings, introducing AI-driven transaction matching and improved identity verification features.

During the quarter, 36 new licensee agreements were signed, reflecting HUB24’s expanding reach, and the number of advisers using its platform grew by 11% year on year.

What’s next for HUB24?

Looking ahead, HUB24 aims to build on its momentum by further investing in product innovation and adviser support. Plans include the pilot launch of ‘myhub’, an AI-powered advice ecosystem, in the first half of FY27.

Structural industry trends, such as strong demand for financial advice and evolving superannuation regulations, are expected to underpin ongoing growth. HUB24 says it is well positioned with a solid pipeline of new opportunities across both new and existing relationships.

HUB24 share price snapshot

Over the past 12 months, HUB24 shares have declined 18%, trailing the S&P/ASX 200 Index (ASX: XJO), which has risen 1% over the same period.

View Original Announcement

The post HUB24 earnings: Record $18.9bn net inflows lift FUA appeared first on The Motley Fool Australia.

More reading

• Contact Energy June 2026 earnings: Sales rise, renewables progress
• Telix Pharmaceuticals: Q2 2026 revenue jumps 21%
• 4 ASX share tips from 4 brokers, for returns better than 40%
• 5 things to watch on the ASX 200 on Tuesday
• Here are the top 10 ASX 200 shares today

Motley Fool contributor Laura Stewart has no position in any of the stocks mentioned. The Motley Fool Australia’s parent company Motley Fool Holdings Inc. has positions in and has recommended Hub24. The Motley Fool Australia has recommended Hub24. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips. This article was prepared with the assistance of Large Language Model (LLM) tools for the initial summary of the company announcement. Any content assisted by AI is subject to our robust human-in-the-loop quality control framework, involving thorough review, substantial editing, and fact-checking by our experienced writers and editors holding appropriate credentials. The Motley Fool Australia stands behind the work of our editorial team and takes ultimate responsibility for the content published by The Motley Fool Australia.

Alkane Resources Ltd (ASX:ALK) has built its cash pile to $432 million and is now proposing to pay a maiden dividend as a result.

Strong production bolsters balance sheet

The company said in a statement to the ASX that its cash holdings increased by $104 million for the quarter, allowing it to initiate the new capital management plan.

Alkane said it produced 42,491 ounces of gold equivalent for the quarter at an all-in sustaining cost of $3011 per ounce, bringing full year gold production to 168,337 ounces.

The company said it expected gold production for the current year to come in at 163,000-177,000 ounces of gold equivalent at an all-in sustaining cost of $2900-$3200 per ounce.

Managing director Nic Earner said it was a good end to the year for the company.

It has been another great quarter for Alkane, producing 40,949 ounces of gold and 456 tonnes of antimony (42,491 ounces of gold equivalent) over the full quarter, which places full year FY26 production at 168,337 ounces of gold equivalent, in the top half of guidance. Our site operating cashflow was $174 million for the quarter, resulting in a balance sheet with $454 million in cash, bullion and listed investments at quarter end. Reflecting this strong financial position and our confidence in the business, the Board has proposed Alkane’s first ever dividend of 2 cents per share, fully franked — a significant milestone for the Company and a tangible return to the shareholders who have supported our growth.

Exploration success building for the future

Alkane also recently announced more exploration success at its Costerfield operation in central Victoria.

The company said on 14 July it had drilled 91 holes targeting the Brunswick South Deposit and the drilling had identified a high-grade antimony and gold grade connection between the recently discovered gold dominant zone at depth and the historical surface workings.

The company added:

Drilling is continuing to identify extensions to the deeper gold dominant zone (Kiwi zone) with recent geological interpretation indicating the setting for mineralisation is similar to that of the Youle deposit currently being mined.

Mr Earner said regarding the results:

Focused extension and infill drilling at Brunswick South over the previous year has produced highly encouraging results. This newly defined deposit not only contains pockets of high gold endowment, but critically a significant quantity of antimony. Excitingly Brunswick South can be brought online without extensive access requirements as it is situated 200m from existing development. We are commencing development towards Brunswick South in the current quarter and are looking to establish it as a primary production source for Costerfield.

Alkane is valued at $1.78 billion.

The post This ASX gold miner has just proposed a maiden dividend payment appeared first on The Motley Fool Australia.

More reading

• 13 ASX 200 shares that doubled in value in FY26

Motley Fool contributor Cameron England has no position in any of the stocks mentioned. The Motley Fool Australia’s parent company Motley Fool Holdings Inc. has no position in any of the stocks mentioned. The Motley Fool Australia has no position in any of the stocks mentioned. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

Since hitting multi-year highs back in March, it has been a steady decline for ASX gold stock Regis Resources Ltd (ASX: RRL). 

It is an established multi-mine gold producer and one of the largest ASX-listed gold producers with an all-Australian asset base. 

The Duketon Gold Project (located in the Laverton region of WA) is RRL’s flagship project. 

Rollercoaster for gold stocks 

Like many other ASX gold stocks, it enjoyed a surge into early 2026 as the gold price climbed to record highs. 

This was driven by strong safe-haven demand, expectations of lower interest rates in major economies, central bank buying, and investor optimism that miners’ profits and cash flows would increase. 

However, like much of the sector, Regis Resources shares have since fallen as gold prices retreated from their peaks, and investors rotated into riskier assets amid improving market sentiment. 

Since peaking at over $9.40 per share in March, it has now fallen over 40% and is now sitting at around $5.65 per share. 

However, this ASX gold stock is now generating broker interest. 

Yesterday, the team at Bell Potter updated their outlook on Regis Resources, which included a retained buy recommendation and strong upside. 

Here’s what the broker had to say. 

FY27 guidance lifted

Late last week, Regis Resources released an updated FY27 outlook. 

As Laura Steward reported, the company lifted its FY27 production guidance, aiming for 360,000–400,000 ounces of gold at a group all-in sustaining cost of $2,990–$3,390 per ounce.

Bell Potter said this production is similar to FY26. 

Higher production at Duketon should offset slightly lower production at Tropicana. 

Costs are expected to rise because the company is mining more expensive ounces and facing higher diesel costs. 

Ramelius is also increasing spending on mine development and exploration, which should support future growth but will lift capital spending in FY27.

Healthy upside for ASX gold stock

Based on this guidance, Bell Potter retained its buy recommendation on this ASX gold stock. 

However the broker has lowered its price target to $8.45 (previously $9.45). 

However, from yesterday’s closing price, this still indicates an upside of almost 50%. 

Overall, we remain positive towards RRL’s all-Australian, multi-mine asset portfolio, leverage to the gold price and its fully unhedged, debt free position. However, higher costs and CAPEX cut our NPV-based valuation 11%, to $8.45/sh. We retain our Buy recommendation.

Bell Potter isn’t the only expert tipping a rebound for gold stocks.

Recently, the VanEck published a report suggesting many ASX gold shares remain attractively valued after the recent pullback.

The post Broker jumps on board this quality ASX gold stock and tips 50% upside appeared first on The Motley Fool Australia.

More reading

• Which ASX gold stock has Macquarie tipped to jump more than 20%?
• 5 things to watch on the ASX 200 on Tuesday
• Regis Resources upgrades FY27 production guidance and cost outlook
• Buy, hold, sell: Regis Resources, Mineral Resources, Woolworths shares
• Regis Resources steps back from Vault Minerals bid, secures break fee

Motley Fool contributor Aaron Bell has no position in any of the stocks mentioned. The Motley Fool Australia’s parent company Motley Fool Holdings Inc. has no position in any of the stocks mentioned. The Motley Fool Australia has no position in any of the stocks mentioned. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

These three ASX healthcare stocks have staged a remarkable comeback in recent weeks.

The latest recovery follows a brutal 12 months for the sector.

The S&P/ASX 200 Health Care Index (ASX: XHJ) fell 39% over the year to a nine-year low on 3 June 2026. Since then, the sector has bounced roughly 20% in a single month.

The broader S&P/ASX 200 Index (ASX: XJO) has risen just 0.1% over the same period.

So which stocks deserve a spot on your watchlist right now?

Let’s take a look at three.

Why ASX healthcare stocks are rebounding

Healthcare was the worst-performing sector on the ASX in FY26.

Why? A stronger Australian dollar, higher costs, and regulatory uncertainty all weighed on returns.

When a sector falls that far that fast, bargain hunters tend to circle, and that is exactly what has been happening since early June.

Institutional investors have rotated out of resources and into beaten-down healthcare names.

Here are three ASX healthcare stocks riding that recovery.

Pro Medicus

Pro Medicus Ltd (ASX: PME) is one of the highest-quality software businesses on the ASX.

The company’s Visage platform helps hospitals view, manage, and share medical images.

Over the last year, PME shares have been on a wild ride.

Shares sank to a 52-week low of $107.75 on 24 February before rebounding sharply. In good news for the company, the recovery has largely been fuelled by a run of new contract wins and renewals.

Brokers remain optimistic, too.

According to Morgans, the broker has reaffirmed an accumulate rating and $230.00 price target on Pro Medicus shares. Citi is even more upbeat, with a buy rating and a $240 target.

Telix Pharmaceuticals

Telix Pharmaceuticals Ltd (ASX: TLX) is the ASX’s flagship radiopharmaceutical company.

The company develops targeted radiation products to image and treat cancer.

Unfortunately, the stock has been volatile over the past year, but there is plenty happening beneath the surface.

Telix has struck a strategic radiopharma collaboration with US biotech Regeneron under which the two companies will co-develop and co-commercialize next-generation radiopharmaceutical therapies on a 50/50 cost-and-profit-sharing basis. Under this deal, Telix will gain access to Regeneron’s antibody platform. Telix will also be able to expand its reach in solid-tumour radiopharma without bearing the full development burden itself

The company also has several FDA catalysts in 2026, led by the resubmitted NDA for TLX101-Px, branded Pixclara, an investigational PET imaging agent for glioma that the FDA accepted in April.

Perhaps as a result, management has guided to FY26 revenue of US$950 million to US$970 million.

For investors comfortable with greater levels of risk, Telix is an intriguing option among ASX healthcare stocks.

CSL

CSL Ltd (ASX: CSL) is the giant of these three ASX healthcare stocks.

The blood products and vaccines business lost around half its value over the past year, a de-rating that has wiped out years of gains.

However, the tide may be turning.

CSL shares have surged about 35% since their early-June low to $122.89.

Broker views remain split.

Morgans has a buy rating and $147.59 price target on CSL shares, whilst the consensus target sits near $140.15, implying roughly 14% upside.

The key test for CSL shares comes with the FY26 result on 19 August.

Foolish takeaway for ASX healthcare stocks

These three ASX healthcare stocks each tell a different story.

Pro Medicus offers quality and momentum. Telix offers pipeline optionality. CSL offers a potential turnaround at a beaten-down price.

All three carry risk, and recoveries can stall.

But for investors hunting the next leg of the rebound, these ASX healthcare stocks are well worth watching.

The post Top 3 ASX healthcare stocks to watch appeared first on The Motley Fool Australia.

More reading

• Telix Pharmaceuticals: Q2 2026 revenue jumps 21%
• CSL vs Telstra shares, which should I buy?
• I’d listen to Warren Buffett and buy cheap ASX shares
• Buy, hold, sell: Weebit Nano, Metals X, Pro Medicus shares
• Down 50%+: Are these ASX healthcare shares finally worth buying?

Motley Fool contributor Mark Verhoeven has no position in any of the stocks mentioned. The Motley Fool Australia’s parent company Motley Fool Holdings Inc. has positions in and has recommended CSL and Telix Pharmaceuticals. The Motley Fool Australia’s parent company Motley Fool Holdings Inc. has recommended Pro Medicus. The Motley Fool Australia has recommended CSL, Pro Medicus, and Telix Pharmaceuticals. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

The Andean Silver Ltd (ASX: ASL) share price is in focus today after the company pinpointed a bonanza-grade silver-gold trend at its Cerro Bayo Project’s Juanita prospect, returning surface samples up to 62,663 grams per tonne silver equivalent.

What did Andean Silver report?

• Surface sampling at Juanita prospect returned assays up to 62,663g/t silver equivalent (25,047g/t Ag & 453.2g/t Au), or 755g/t gold equivalent
• High-grade breccia zone defined over 2 kilometres strike length, with observed widths up to 18 metres
• Historic drilling and channel results include 17.1m @ 194g/t AgEq and 1.6m @ 1,209g/t AgEq
• Juanita sits outside the existing Cerro Bayo 136Moz AgEq mineral resource
• Andean Silver held $53.4 million in cash at the end of March quarter 2026

What else do investors need to know?

The Juanita discovery marks the third major greenfield exploration area identified by Andean Silver at Cerro Bayo, indicating a pathway for further growth beyond current resources. Juanita’s mineralisation differs from the typical epithermal veins of the district, displaying high-grade precious metals across multiple events and a large breccia system.

Recent mapping suggests past drilling was limited, with much of Juanita’s most prospective zones remaining untested. The company is now embarking on detailed geological work and systematic sampling along the 2-kilometre trend to firm up priority drill targets.

What did Andean Silver management say?

Andean Silver Managing Director Matthew Allen said:

Juanita is emerging as a potentially significant silver-gold prospect. Its mineralisation differs from the vein-style deposits common across the Company’s tenure, with high-grade silver and gold occurring over a substantial strike length and through multiple mineralising events.

Juanita historically has remained underexplored for 20 years due to the subtle surface expression of the system exposed on surface and limited intersection in historic scout drilling.

Juanita represents a third new large exploration area identified outside the existing resources at the Cerro Bayo Project, which include the Guanaco and Droughtmaster corridors, building Andean’s future prospect pipeline.

What’s next for Andean Silver?

Andean Silver plans to accelerate mapping, channel sampling, and drill planning at Juanita, targeting high-grade zones for maiden drill tests. Broader objectives include ramping up both brownfields and greenfields exploration throughout Cerro Bayo to grow resources and restart production.

The company is well funded to support these campaigns, with feasibility and resource upgrade studies running in parallel. Andean aims to transition Cerro Bayo from an exploration project into a near-term development and production asset by late 2027.

Andean Silver share price snapshot

Over the past 12 months, Andean Silver shares have risen 31%, outperforming the S&P/ASX All Ords Index (ASX: XAO), which has risen 1% over the same period.

View Original Announcement

The post Andean Silver Bonanza silver-gold unearthed at Cerro Bayo’s Juanita prospect appeared first on The Motley Fool Australia.

More reading

• Ophir High Conviction Fund announces FY26 unfranked distribution
• 5 ASX All Ords shares that ripped 200% to 400% in FY26

Starting an investment portfolio can feel harder than it needs to be.

There are thousands of shares to choose from and plenty of market noise.

The good news for beginners is that ASX exchange traded funds (ETFs) can make the first step simpler.

This is because they offer investors exposure to a basket of shares in one easy trade.

With that in mind, here are five ASX ETFs that I think could be good options for beginner investors in July.

Vanguard MSCI Index International Shares ETF (ASX: VGS)

The Vanguard MSCI Index International Shares ETF could be a good starting point.

It gives investors exposure to over a thousand companies across developed markets. That means investors are not relying only on Australia’s banks, miners, and supermarkets to drive returns.

This fund can work as a global foundation because it spreads money across countries, sectors, currencies, and businesses. A beginner does not need to know which overseas company will be the next big winner to get started.

Vanguard Australian Shares Index ETF (ASX: VAS)

But if you do want some exposure to the local market, the Vanguard Australian Shares Index ETF could be worth considering.

This fund tracks a large basket of Australian shares, including banks, miners, healthcare shares, retailers, property groups, infrastructure businesses, and industrial companies.

Australian shares can also be attractive because of dividends and franking credits. The local market is not as broad as the US or global markets, but it still gives investors exposure to some strong, cash-generating businesses.

Betashares Nasdaq 100 ETF (ASX: NDQ)

For US exposure, the Betashares Nasdaq 100 ETF is worth considering.

It invests in 100 of the largest non-financial companies listed on the Nasdaq exchange.

These are businesses linked to areas such as artificial intelligence, cloud computing, software, chips, digital advertising, streaming, ecommerce, and consumer technology.

This fund will likely be more volatile than a broad market ETF, so beginners should understand that it can fall sharply at times.

But over the long term, it gives exposure to some of the companies shaping how people work, shop, communicate, and use technology. That is likely to be a good thing over the next decade.

Betashares Global Cybersecurity ETF (ASX: HACK)

Another ASX ETF to look at is the Betashares Global Cybersecurity ETF.

It gives investors easy access to companies helping protect networks, data, cloud systems, devices, payments, and digital identities.

Cybersecurity is becoming a larger cost for businesses as more activity moves online. The risks are also growing as companies use more cloud software, remote access, artificial intelligence tools, and connected systems.

This means that it gives beginners exposure to a long-term theme that should remain relevant as the digital economy expands.

VanEck Morningstar Wide Moat ETF (ASX: MOAT)

Finally, the VanEck Morningstar Wide Moat ETF could be worth a closer look.

This ASX ETF takes a selective approach to US shares. It looks for companies believed to have sustainable competitive advantages and attractive valuations.

In many respects, it mirrors the approach that legendary investor Warren Buffett used during his highly successful career.

This fund could appeal to beginners who want something more targeted than a standard index fund, but not as narrow as a single-sector ETF.

The post 5 ASX ETFs for beginner investors in July appeared first on The Motley Fool Australia.

More reading

• Best money-saving techniques to build long-term wealth
• 3 ASX ETFs that make long-term investing easy
• VAS vs VGS: Which Vanguard ETF is winning so far this year?
• Should I target high growth or balanced strategies for my superannuation?
• 3 super ASX ETFs to buy and hold until 2046

Motley Fool contributor James Mickleboro has positions in BetaShares Nasdaq 100 ETF and VanEck Morningstar Wide Moat ETF. The Motley Fool Australia’s parent company Motley Fool Holdings Inc. has positions in and has recommended BetaShares Global Cybersecurity ETF and BetaShares Nasdaq 100 ETF. The Motley Fool Australia has positions in and has recommended BetaShares Nasdaq 100 ETF. The Motley Fool Australia has recommended VanEck Morningstar Wide Moat ETF and Vanguard Msci Index International Shares ETF. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.